More than 200,000 Australians who are immunocompromised will gain free access to the shingles vaccine in an expansion of a ...

Shields has been vocal about women's wellness and now backs an initiative for women to be aware of an infection that's ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Closer takes a look at five vaccines you should get after you turn 50 to help protect against illness. Shingles: “The first ...

GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

Responding to rising mpox cases in Africa, the World Health Organization declared a public health emergency of international ...

GSK (GSK) reached the main goal in a Phase 3 trial for its RSV shot, Arexvy co--administered with Shingles vaccine Shingrix.

GSK plc (GSK, GSK.L) announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...

There may be better ways to plan for your retirement than to constantly scrimp on your budget. We know that people think they ...